Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
ProSomnus (NASDAQ:OSA) reported quarterly sales of $7.84 million which beat the analyst consensus estimate of $7.37 million by 6.35 percent. This is a 35.32 percent increase over sales of $5.79 million the same period last year.
Posted In: OSA